Scholarlink

This is a case with a clear cell kidney carcinoma patient on nivolumab treatment who developed ICI related sicca syndrome. Her sicca syndrome was successfully treated with a combination of prednisone and hydroxychloroquine, which were eventually tapered off. Her cancer remained in remission while on an immunosuppressant for 26 weeks for sicca syndrome and other immune related adverse events.

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Sicca Syndrome Induced by Immune Checkpoint Inhibitor Therapy

  • 章节

  • 发表日期：

    2025年

查看全文
  • Yuanteng Jeff Li,
  • Sang T. Kim,
  • Nizar M. Tannir,
  • Huifang Lu

摘要

This is a case with a clear cell kidney carcinoma patient on nivolumab treatment who developed ICI related sicca syndrome. Her sicca syndrome was successfully treated with a combination of prednisone and hydroxychloroquine, which were eventually tapered off. Her cancer remained in remission while on an immunosuppressant for 26 weeks for sicca syndrome and other immune related adverse events.